Selective cyclooxygenase-2 inhibitors (coxibs), a type of nonsteroidal antiinflammatory drug (NSAID), were introduced in December 1998. The antiinflammatory activity of these agents is similar to ...

Possible Role of Cyclooxygenase-2 in Schistosomal and Non-Schistosomal-Associated Bladder Cancer Olfat Ali Hammam, MD; Ahmed A. Aziz, MD; Mamdouh S. Roshdy, MD; Ahmed M. Abdel Hadi, MD Disclosures ...

Purpose: A summary of the basic science underlying the current controversies regarding cyclooxygenase-2 (COX-2)-selective nonsteroidal antiinflammatory drugs (NSAIDs), including data on their ...

Correspondence The Coxibs, Selective Inhibitors of Cyclooxygenase-2 Published December 6, 2001 N Engl J Med 2001;345: 1708 - 1709 DOI: 10.1056/NEJM200112063452314 ...

Cyclooxygenase-2 (Cox-2), the gastrin-release peptide (GRP) and its cognate receptor (GRP-R) are overexpressed in a significant percentage of colorectal carcinomas and are associated with cell ...

Increased Cyclooxygenase-2 Expression Is Associated With Chemotherapy Resistance and Poor Survival in Cervical Cancer Patients Authors: G. Ferrandina, L. Lauriola, M. G. Distefano, G. F. Zannoni, M.

Overexpression of cyclooxygenase-2 (COX-2) is common in non–small-cell lung cancer (NSCLC) and is associated with poor prognosis. 1 - 3 COX-2 has been shown to be expressed not only in the tumor cells ...